Borse Kadambari, Shende Pravin
Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM'S NMIMS, V. L. Mehta Road, Vile Parle (W), Mumbai, India.
Drug Deliv Transl Res. 2024 Dec 11. doi: 10.1007/s13346-024-01752-1.
The present study aimed to synthesize tiotropium bromide (TIO)-loaded generation 5 polyamidoamine dendrimers (TIO-PAMAM-G5-DMs) using a solvent-free microwave assisted synthesis (MAS) for the treatment of pulmonary acidosis, a condition associated with decreased blood pH due to bronchoconstriction. The encapsulation of TIO into PAMAM-G5-DMs was achieved using MAS Michael addition and amidation reactions, following green chemistry principles. The DMs demonstrated particle size of 460.68 ± 1.38 nm, entrapment efficiency of 92.4 ± 0.44%, controlled release profiles of 90.4 ± 0.62% and 76 ± 0.84% in media of pH 6.8 and 7.4, respectively, and high buffering capacity (25 mL/pH units) using a proton sponge effect for the release of the drug into the system as compared to the conventional formulation. A synergistic rat model was used to compare the pharmacokinetics (PK) of marketed and DM-based formulations. The results showed a mean C of 1987 ng/mL, t of 6 h, AUC of 10013863.5 ng.h/mL, and t½ of 18.59 h, respectively. The DMs exhibited low cytotoxicity, good biocompatibility, and higher IC value (> 10 µg) on human lung epithelial cell line BEAS-2B. Thus, our study introduces a cutting-edge alternative approach for treating pulmonary acidosis using PAMAM-DMs with proton sponge effect.
本研究旨在采用无溶剂微波辅助合成法(MAS)合成负载噻托溴铵(TIO)的第5代聚酰胺-胺树枝状大分子(TIO-PAMAM-G5-DMs),用于治疗肺酸中毒,这是一种因支气管收缩导致血液pH值降低的病症。按照绿色化学原理,通过MAS迈克尔加成反应和酰胺化反应将TIO包封到PAMAM-G5-DMs中。所制备的树枝状大分子在pH 6.8和7.4介质中的粒径分别为460.68±1.38 nm、包封率为92.4±0.44%、控释率分别为90.4±0.62%和76±0.84%,并且与传统制剂相比,利用质子海绵效应将药物释放到系统中时具有高缓冲容量(25 mL/pH单位)。使用协同大鼠模型比较市售制剂和基于树枝状大分子的制剂的药代动力学(PK)。结果显示,平均血药浓度C为1987 ng/mL、达峰时间t为6 h、药时曲线下面积AUC为10013863.5 ng·h/mL、半衰期t½为18.59 h。该树枝状大分子在人肺上皮细胞系BEAS-2B上表现出低细胞毒性、良好的生物相容性和较高的半数抑制浓度值(>10 μg)。因此,我们的研究引入了一种前沿的替代方法,即使用具有质子海绵效应的PAMAM-DMs治疗肺酸中毒。